NCT04211064

Brief Summary

Increased intracranial pressure (IICP) is a common problem in traumatic brain injuries and many medical diseases. Early recognition of IICP can save lives. Several invasive and non-invasive methods have been described for IICP diagnosis. In recent years, ultrasonographic measurement of optic nerve sheath diameter (ONSD) has become a popular method due to its high sensitivity and specificity for IICP estimation. Studies have shown that ONSD's ultrasonographic measurement correlates with the IICP and can detect intracranial hypertension. The ONSD measurement has advantages such as being easily applied by the clinician at the bedside, being non-invasive, providing immediate results, reproducibility and low cost. It is known that artificial carbon dioxide pneumoperitoneum created in laparoscopic surgeries increases intracranial pressure.However, it is not easy to estimate the degree of changes in ICP during laparoscopic surgery under general anesthesia. In the literature, there are many studies on the sonographic measurement of optic nerve sheath diameter to evaluate the effects of trendelenburg position on intracranial pressure with the use of different anesthetic drugs in laparoscopic surgeries. In addition, there are studies reporting that deep neuromuscular blockade in laparoscopic surgeries increases surgical vision and decreases analgesic requirement in postoperative period. The relationship between neuromuscular block level and intracranial pressure is not clear. From this point of view, the investigators would like to evaluate the effect of moderate and deep neuromuscular block level on intracranial pressure by sonographic measurement of optic nerve sheath diameter in laparoscopic cholecystectomy operations performed with standard pressure artificial carbon dioxide pneumoperitoneum.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2021

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 4, 2019

Completed
22 days until next milestone

First Posted

Study publicly available on registry

December 26, 2019

Completed
1.7 years until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2022

Completed
Last Updated

September 13, 2021

Status Verified

September 1, 2021

Enrollment Period

4 months

First QC Date

December 4, 2019

Last Update Submit

September 6, 2021

Conditions

Keywords

optic nerve sheath diameterdeep neuromuscular blockmoderate neuromuscular blockintracranial hypertension

Outcome Measures

Primary Outcomes (1)

  • Optic nerve sheath diameter

    Sonographic optic nerve sheath measurements will be made 5 times, preoperatively, 5 minutes after endotracheal intubation, 5 minutes after pneumoperitoneum, 5 minutes after pneumoperitoneum is terminated and after extubation

    During surgery

Secondary Outcomes (3)

  • Headache

    24 hours

  • Postoperative nausea and vomiting score

    24 hours

  • Patient satisfaction score

    24 hours

Study Arms (2)

Deep neuromuscular block

OTHER

Patients undergoing deep neuromuscular blockade with rocuronium (TOF -- PTC 1-5)

Diagnostic Test: Ultrasonographic measurement of optic nerve sheath diameterProcedure: Deep neuromuscular block

Moderate neuromuscular block

ACTIVE COMPARATOR

Patients undergoing moderate neuromuscular blockade with rocuronium (TOF 1-3)

Diagnostic Test: Ultrasonographic measurement of optic nerve sheath diameterProcedure: Moderate neuromuscular block

Interventions

Optic nerve sheath diameter will be measured at both neuromuscular blocks level.

Deep neuromuscular blockModerate neuromuscular block

Deep neuromuscular block will be obtained via appropriate dose of rocuronium.

Deep neuromuscular block

Moderate neuromuscular block will be obtained via appropriate dose of rocuronium.

Moderate neuromuscular block

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Between 18-65 years
  • ASA I-II
  • Patients undergoing elective laparoscopic cholecystectomy

You may not qualify if:

  • Intracranial hypertension
  • Glaucoma
  • Chronic obstructive pulmonary disease
  • Pseudotumor cerebri
  • Cerebral venous sinus thrombosis
  • İntraoperative hemodynamic instability
  • Mean arterial blood pressure\<65 mmHg
  • Body mass index\> 35
  • Asthma
  • Kidney or liver problems
  • Lupus
  • Crohn's disease or ulcerative colitis
  • Previously had any gastrointestinal bleeding
  • Hypertension
  • Peripheral arterial disease
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Intracranial Hypertension

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Serdar Yeşiltaş, Instructor

    BEZMİALEM VAKIF UNIVERSITY

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Serdar Yeşiltaş, Instructor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
The participants were blinded to group allocation, as the measurements were performed after induction of general anesthesia. The investigator measuring the optic nerve sheath diameter was blinded to the group assignment.
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Patients will be randomly divided into 2 groups. In the first group (Group 1), patients undergoing intraabdominal insufflation pressure 12 mmHg and deep neuromuscular block (TOF -- PTC 1-5), in the second group (Group 2) patients undergoing intraabdominal insufflation pressure 12 mmHg and moderate neuromuscular block (TOF 1-3) It would be classified.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator, Medical Doctor, Anesthesiology and Reanimation

Study Record Dates

First Submitted

December 4, 2019

First Posted

December 26, 2019

Study Start

September 1, 2021

Primary Completion

January 1, 2022

Study Completion

February 1, 2022

Last Updated

September 13, 2021

Record last verified: 2021-09